Specialty therapeutics company focused on gastrointestinal and hepatology diseases and programs

Sectors
Healthcare
Life Sciences
First Invested
2006
Early
Company Status
IPO/Acquired
NASDAQ: HPTX
Acquired by Horizon Pharma